Syntheses are described of some mono- and di-glycosylated analogues of vespulakinin 1. The solid phase procedure, based on the Fmoc chemistry, was used to prepare (Gal-alpha)Thr3-vespulakinin 1, (Gal-beta)Thr3-vespulakinin 1 and the di-glycosylated analogue ((Gal-alpha)Thr3, (Gal-alpha)Thr4-vespulakinin 1. The beta-glycosylated derivative was also prepared by the continuous flow variant of the Fmoc polyamide method. The synthesized glycopeptides were purified and characterized by amino acid analysis, optical rotation, analytical HPLC, H-1- and C-13-NMR and FAB-MS. Preliminary pharmacological experiments showed that the carbohydrate-free vespulakinin 1 is less active than bradykinin (about 0.3 times on a molar basis) when tested by guinea pig rectum contraction, and the two monoglycosylated analogues are equiactive (about 0.9 times the bradykinin activity). The most active derivative, the (Gal-alpha)Thr3, (Gal-alpha)Thr4-vespulakinin 1 analogue, was about 2.5 times as active as bradykinin.

Synthesis and Biological-activity of the Mono-galactosyl-vespulakinin-1 and Di-galactosyl-vespulakinin-1 Analogs

GOBBO, MARINA;BIONDI, LAURA;FILIRA, FERNANDO;SCOLARO, BARBARA;ROCCHI, RANIERO;
1992

Abstract

Syntheses are described of some mono- and di-glycosylated analogues of vespulakinin 1. The solid phase procedure, based on the Fmoc chemistry, was used to prepare (Gal-alpha)Thr3-vespulakinin 1, (Gal-beta)Thr3-vespulakinin 1 and the di-glycosylated analogue ((Gal-alpha)Thr3, (Gal-alpha)Thr4-vespulakinin 1. The beta-glycosylated derivative was also prepared by the continuous flow variant of the Fmoc polyamide method. The synthesized glycopeptides were purified and characterized by amino acid analysis, optical rotation, analytical HPLC, H-1- and C-13-NMR and FAB-MS. Preliminary pharmacological experiments showed that the carbohydrate-free vespulakinin 1 is less active than bradykinin (about 0.3 times on a molar basis) when tested by guinea pig rectum contraction, and the two monoglycosylated analogues are equiactive (about 0.9 times the bradykinin activity). The most active derivative, the (Gal-alpha)Thr3, (Gal-alpha)Thr4-vespulakinin 1 analogue, was about 2.5 times as active as bradykinin.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11577/2510885
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 14
social impact